Study of Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab (AMG 827) in Moderate to Severe Plaque Psoriasis Subjects (AMAGINE-1)

Clinical Trial ID NCT01708590

PubWeight™ 9.41^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01708590

Top papers